We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Comparison Between Tramadol Hcl and Other Analgesics in the Treatment of Renal Colic

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00310908
Recruitment Status : Completed
First Posted : April 5, 2006
Last Update Posted : February 17, 2009
Information provided by:
Hadassah Medical Organization

Brief Summary:
The purpose of this study is to determine whether Tramadol Hcl is as effective as Voltaren a non-steroidal antiinflammatory drug, and Dipyrone in amelioration of the pain caused by acute renal colic.

Condition or disease Intervention/treatment Phase
Renal Calculus Drug: Tramadol Hcl Phase 4

Detailed Description:
Renal stones is a common condition affecting up to 1% of the american population. The main symptom is renal colic. Acute treatment is based on the administration of analgesics mainly those belonging to non-steroidal antiinflammatory drugs (NSAIDs). Tramadol is an analgesic of the opioid class of analgesics (i.e morphine) and it is considered to cause less side effects with more or less the same analgesic potency. In the present study the analgesic effect of intramuscular Tramadol will be compared with Voltaren (NSAID)in patients attending the Emergency Department (ED) for acute renal colic (Stage I). Most of these patients will not pass their stone during their visit to the ED and they are prone to develop another attack of renal colic.In the second phase of the study (Stage II)patients who improved, and are ready to go home, will be enrolled to get Dipyrone or Tramadol orally for the prevention of further pain.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Efficacy of Tramadol Hcl in the Treatment of Renal Colic
Study Start Date : September 2006
Actual Primary Completion Date : February 2009
Actual Study Completion Date : February 2009

Resource links provided by the National Library of Medicine

Intervention Details:
  • Drug: Tramadol Hcl
    Active Comparator

Primary Outcome Measures :
  1. Pain improvement according to VAS score at 30, 60 and 120 minutes(Stage I) [ Time Frame: 30, 60, 120 minutes ]
  2. Need for rescue medication at 30 minutes (Stage I) [ Time Frame: 30 minutes ]
  3. Pain improvement according to VAS score at 24 and 48 hrs (Stage II) [ Time Frame: 24 and 48 hrs ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients with clinical diagnosis of acute renal colic (Stage I)
  • Patients with diagnosed renal colic who might need prevention of pain and are able to swallow medicines (Stage II)

Exclusion Criteria:

  • Patients with known hypersensitivity to the study drugs
  • Pregnancy or lactation
  • Known renal failure or hepatic disease
  • Concommitant drug use which could adversely affect patient's outcome (oral anticoagulant, MAO inhibitors)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00310908

Layout table for location information
Hadassah Medical Organization
Jerusalem, Israel, 12000
Sponsors and Collaborators
Hadassah Medical Organization
Layout table for investigator information
Principal Investigator: Ruth Stalnikowicz, MD Hadassah Medical Organization
Publications of Results:
Layout table for additonal information
Responsible Party: Ruth Stalnikowicz, Hadassah Medical Organization
ClinicalTrials.gov Identifier: NCT00310908    
Other Study ID Numbers: 1234567-HMO-CTIL
First Posted: April 5, 2006    Key Record Dates
Last Update Posted: February 17, 2009
Last Verified: September 2006
Keywords provided by Hadassah Medical Organization:
Additional relevant MeSH terms:
Layout table for MeSH terms
Kidney Calculi
Renal Colic
Pathological Conditions, Anatomical
Neurologic Manifestations
Kidney Diseases
Urologic Diseases
Urinary Calculi
Analgesics, Opioid
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents